Proteomics

Dataset Information

0

Mesoporous Silica Nanoparticles Induce Early Cholestatic Hepatotoxicity Characterized by Elevated Serum Bile Acids, CYP7A1/CYP8B1 Enzyme Reprogramming, and BSEP Transporter Suppression

ABSTRACT: TMT-based quantitative proteomics to comprehensively characterize hepatic responses to repeated intravenous MSN administration.

ORGANISM(S): Mus Musculus

SUBMITTER: Jing li  

PROVIDER: PXD080703 | iProX | Tue Jul 07 00:00:00 GMT+01:00 2026

REPOSITORIES: iProX

Json Xml

Similar Datasets

Unknown Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases.
| S-EPMC8056274 | biostudies-literature
Unknown The role of bile acids in cholestatic liver injury.
| S-EPMC8106037 | biostudies-literature
Unknown Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
| S-EPMC10244448 | biostudies-literature
Unknown Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease.
| S-EPMC10222613 | biostudies-literature
Unknown A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity.
| S-EPMC9395349 | biostudies-literature
Unknown Bile Acids Gate Dopamine Transporter Mediated Currents.
| S-EPMC8702627 | biostudies-literature
Unknown Ileal bile acid transporter inhibition in Cyp2c70 KO mice ameliorates cholestatic liver injury.
| S-EPMC9460185 | biostudies-literature
Unknown Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.
| S-EPMC5333973 | biostudies-literature
Unknown Maralixibat Reduces Serum Bile Acids and Improves Cholestatic Pruritus in Adolescents With Alagille Syndrome.
| S-EPMC11740003 | biostudies-literature
Proteomics A Novel Differentiated HuH-7 Cell Model to Examine Bile Acid Metabolism, Transport and Cholestatic Hepatotoxicity
2022-10-14 | PXD031731 | Pride